Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.19
-0.50 (-7.41%)
At close: Aug 14, 2025, 4:00 PM
6.17
-0.01 (-0.24%)
After-hours: Aug 14, 2025, 4:00 PM EDT

Solid Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
482160124105193499
Upgrade
Market Cap Growth
73.47%29.00%17.92%-45.57%-61.33%143.92%
Upgrade
Enterprise Value
234138-11-34480
Upgrade
Last Close Price
6.684.006.145.3826.25113.70
Upgrade
PS Ratio
---12.9814.17-
Upgrade
PB Ratio
2.011.160.980.500.933.78
Upgrade
P/TBV Ratio
1.851.160.980.500.933.78
Upgrade
Debt / Equity Ratio
0.090.180.210.140.010.04
Upgrade
Asset Turnover
---0.030.07-
Upgrade
Quick Ratio
8.984.928.529.498.816.32
Upgrade
Current Ratio
9.345.208.949.769.436.49
Upgrade
Return on Equity (ROE)
-68.25%-94.56%-56.79%-40.96%-42.43%-83.24%
Upgrade
Return on Assets (ROA)
-36.35%-45.86%-30.67%-23.95%-22.38%-39.35%
Upgrade
Return on Capital (ROIC)
-39.22%-51.62%-33.18%-26.20%-25.99%-48.17%
Upgrade
Earnings Yield
-32.17%-78.02%-77.50%-81.84%-37.40%-17.69%
Upgrade
FCF Yield
-25.75%-62.99%-77.24%-96.13%-40.95%-11.52%
Upgrade
Buyback Yield / Dilution
-105.06%-105.27%-133.60%-19.59%-105.58%-28.91%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q